Long QT syndrome – Bench to bedside

Long QT syndrome (LQTS) is a cardiovascular disorder characterized by an abnormality in cardiac repolarization leading to a prolonged QT interval and T-wave irregularities on the surface electrocardiogram. It is commonly associated with syncope, seizures, susceptibility to torsades de pointes, and r...

Full description

Saved in:
Bibliographic Details
Published in:Heart rhythm O2 2021-02, Vol.2 (1), p.89-106
Main Authors: Ponce-Balbuena, Daniela, Deschênes, Isabelle
Format: Article
Language:English
Subjects:
Genetic variants
Induced pluripotent stem cell–derived cardiomyocyte (iPSC-CM)
Long QT syndrome
Potassium channel
Precision medicine
Sodium channel
Topics in Review
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Long QT syndrome (LQTS) is a cardiovascular disorder characterized by an abnormality in cardiac repolarization leading to a prolonged QT interval and T-wave irregularities on the surface electrocardiogram. It is commonly associated with syncope, seizures, susceptibility to torsades de pointes, and risk for sudden death. LQTS is a rare genetic disorder and a major preventable cause of sudden cardiac death in the young. The availability of therapy for this lethal disease emphasizes the importance of early and accurate diagnosis. Additionally, understanding of the molecular mechanisms underlying LQTS could help to optimize genotype-specific treatments to prevent deaths in LQTS patients. In this review, we briefly summarize current knowledge regarding molecular underpinning of LQTS, in particular focusing on LQT1, LQT2, and LQT3, and discuss novel strategies to study ion channel dysfunction and drug-specific therapies in LQT1, LQT2, and LQT3 syndromes. [Display omitted]
ISSN:2666-5018
2666-5018
DOI:10.1016/j.hroo.2021.01.006